JP2023530231A5 - - Google Patents
Info
- Publication number
- JP2023530231A5 JP2023530231A5 JP2022574770A JP2022574770A JP2023530231A5 JP 2023530231 A5 JP2023530231 A5 JP 2023530231A5 JP 2022574770 A JP2022574770 A JP 2022574770A JP 2022574770 A JP2022574770 A JP 2022574770A JP 2023530231 A5 JP2023530231 A5 JP 2023530231A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- group
- hydrogen
- heteroaryl
- carbocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063034248P | 2020-06-03 | 2020-06-03 | |
| US63/034,248 | 2020-06-03 | ||
| US202163183094P | 2021-05-03 | 2021-05-03 | |
| US63/183,094 | 2021-05-03 | ||
| PCT/US2021/035343 WO2021247634A1 (en) | 2020-06-03 | 2021-06-02 | Inhibitors of transcriptional enhanced associate domain (tead) and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023530231A JP2023530231A (ja) | 2023-07-14 |
| JP2023530231A5 true JP2023530231A5 (https=) | 2024-06-12 |
Family
ID=76641834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574770A Withdrawn JP2023530231A (ja) | 2020-06-03 | 2021-06-02 | 転写増強アソシエートドメイン（ｔｅａｄ）阻害剤及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240124406A1 (https=) |
| EP (1) | EP4164752A1 (https=) |
| JP (1) | JP2023530231A (https=) |
| AU (1) | AU2021283892A1 (https=) |
| CA (1) | CA3180846A1 (https=) |
| WO (1) | WO2021247634A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020051424A1 (en) | 2018-09-07 | 2020-03-12 | Pic Therapeutics | Eif4e inhibitors and uses thereof |
| CA3141826A1 (en) | 2019-05-31 | 2020-12-03 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
| CA3142351A1 (en) | 2019-05-31 | 2020-12-03 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
| TW202146393A (zh) | 2020-03-03 | 2021-12-16 | 美商皮克醫療公司 | Eif4e抑制劑及其用途 |
| CA3205726A1 (en) * | 2021-01-25 | 2022-07-28 | Alfredo C. Castro | Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and/or mek inhibitor for use in the treatment of lung cancer |
| AR125350A1 (es) * | 2021-04-16 | 2023-07-12 | Orion Corp | Inhibidores tead |
| CA3229560A1 (en) | 2021-08-25 | 2023-03-02 | Christopher L. Vandeusen | Eif4e inhibitors and uses thereof |
| US12157732B2 (en) | 2021-08-25 | 2024-12-03 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| CA3248299A1 (en) * | 2022-01-14 | 2025-02-28 | Daewoong Pharmaceutical Co., Ltd. | Aminobenzene derivatives and pharmaceutical compositions for the treatment of cancer or tumors |
| WO2023146511A1 (en) * | 2022-01-25 | 2023-08-03 | Vivace Therapeutics, Inc. | Compounds and methods of use thereof |
| WO2023217156A1 (zh) * | 2022-05-09 | 2023-11-16 | 浙江同源康医药股份有限公司 | 多环类化合物及其用途 |
| CN119968359A (zh) | 2022-09-29 | 2025-05-09 | 英矽智能科技知识产权有限公司 | Tead抑制剂及其使用方法 |
| IL320456A (en) * | 2022-10-27 | 2025-06-01 | Suzhou Genhouse Bio Co Ltd | Phosphorus-containing compound, pharmaceutical composition and use thereof |
| WO2024099435A1 (zh) * | 2022-11-10 | 2024-05-16 | 武汉人福创新药物研发中心有限公司 | Tead抑制剂 |
| WO2024255856A1 (zh) * | 2023-06-14 | 2024-12-19 | 赛诺哈勃药业（成都）有限公司 | 一种调控tead活性的化合物、其制备方法及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004018430A1 (ja) * | 2002-08-23 | 2004-03-04 | Kirin Beer Kabushiki Kaisha | ＴＧＦβ阻害活性を有する化合物およびそれを含んでなる医薬組成物 |
| PE20120008A1 (es) * | 2009-01-12 | 2012-01-24 | Icagen Inc | Derivados de fenoxi bencenosulfonamida |
| WO2018204532A1 (en) * | 2017-05-03 | 2018-11-08 | Vivace Therapeutics, Inc. | Non-fused tricyclic compounds |
| US11192865B2 (en) * | 2017-08-21 | 2021-12-07 | Vivace Therapeutics, Inc. | Benzosulfonyl compounds |
| US11524943B1 (en) * | 2017-12-06 | 2022-12-13 | Vivace Therapeutics, Inc. | Benzocarbonyl compounds |
| GB201810668D0 (en) * | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
| US11192900B2 (en) * | 2018-10-30 | 2021-12-07 | Nuvation Bio Inc. | Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors |
| CA3141826A1 (en) * | 2019-05-31 | 2020-12-03 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
-
2021
- 2021-06-02 CA CA3180846A patent/CA3180846A1/en active Pending
- 2021-06-02 US US18/000,049 patent/US20240124406A1/en not_active Abandoned
- 2021-06-02 AU AU2021283892A patent/AU2021283892A1/en not_active Abandoned
- 2021-06-02 EP EP21735521.3A patent/EP4164752A1/en active Pending
- 2021-06-02 JP JP2022574770A patent/JP2023530231A/ja not_active Withdrawn
- 2021-06-02 WO PCT/US2021/035343 patent/WO2021247634A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023530231A5 (https=) | ||
| KR20210126036A (ko) | 화합물, 조성물 및 방법 | |
| KR102354411B1 (ko) | 항바이러스제로서 유용한 아미노티아졸 유도체 | |
| CN108699059B (zh) | 可用于治疗正粘病毒感染的三环化合物 | |
| CN107108492B (zh) | 细胞坏死抑制剂 | |
| KR102708082B1 (ko) | 항바이러스 화합물로서 치환된 티아졸의 거울상 이성질체 | |
| JP2019527682A5 (https=) | ||
| CN110167939B (zh) | 吡咯并[2,3-c]吡啶类衍生物、其制备方法及其在医药上的应用 | |
| JP2019514883A5 (https=) | ||
| TW201920115A (zh) | 化合物、組合物及方法 | |
| CN114539246A (zh) | 一种哌啶并嘧啶类化合物及其用途 | |
| JP2023508982A5 (https=) | ||
| KR102212981B1 (ko) | 4-알키닐이미다졸 유도체 및 그것을 유효 성분으로서 함유하는 의약 | |
| KR102678977B1 (ko) | Cxcr4 저해제로서 헤테로아릴 화합물, 그 조성물 및 이용 방법 | |
| CN103002742A (zh) | 核转运调节剂及其应用 | |
| JP2013506715A5 (https=) | ||
| JP2022513846A5 (https=) | ||
| KR20230035049A (ko) | 화합물, 조성물 및 방법 | |
| CN107207486A (zh) | 用于抑制布罗莫结构域和末端外蛋白质的方法和组合 | |
| JP2017517555A (ja) | 阻害剤ｐ５３−Ｍｄｍ２タンパク質−タンパク質相互作用としての、１，１’，２，５’−テトラヒドロスピロ［インドール−３，２’−ピロール］−２，５’−ジオン系を含む化合物 | |
| CN110156656B (zh) | 五元杂芳环衍生物、其制备方法、药物组合物及应用 | |
| JP2023545588A5 (https=) | ||
| JP2020516616A5 (https=) | ||
| WO2018117196A1 (ja) | がん幹細胞を標的とする医薬 | |
| JP2024517183A5 (https=) |